NF-kB can act as a tumor suppressor and prevent cancer development through the activation of the Claspin–Chk1-mediated checkpoint response, which, early in carcinogenesis, will prevent the accumulation of genetic mutations [80]. The gene discussed is NFKB1; the disease is neoplasm.